Meningitis is a type of rare infection which affects the delicate membranes surrounding the brain and spinal cord that are known as meninges. Meningococcal meningitis is the type of bacterial meningitis that is caused by bacterium Neisseria meningitidis. It can be transmitted to individuals in case people suffering with meningitis sneeze or cough. Infants have a huge risk of getting infected with bacterial meningitis.
Global meningitis vaccines market is forecast to be valued at US$ 4,070.1 Mn in 2022 during the forecast period.
Request Here For The Sample Copy Of The Report @ https://www.coherentmarketinsights.com/insight/request-sample/5042
Impact of COVID-19:
COVID-19 outbreak took place in 2019, December, later the virus was transmitted to 100 nations around the world and on 30 January, 2020, the World Health Organization declared it as a health emergency.
COVID-19 directly affected the economy of the country, as it impacted the production and demand of various products and also creating disturbances in distribution channels. The pandemic also had a financial impact on various firms and the financial markets. Many countries like India, UAE, China, Egypt, Saudi Arabia and many others were facing challenges in transporting products due to lockdowns in several regions.
The pandemic had a negative impact on the global meningitis vaccines market, due to reduction the in vaccination rates for meningitis. For instance, a Netherlands-based academic publishing company, Elsevier B.V., published their data in April 2022, stating that meningococcal C (Men-C) conjugate vaccine doses were analyzed in Brazil, from March 2019 to December 2020. 14,832,054 doses of the vaccine were administered overall, out of which 66.30% doses were administered from March 2019 to February 2020, and from March 2020 to December 2020, only 33.70% doses were given. Thus, the pandemic exhibited a negative impact on the administration of meningitis vaccine doses in the North and South regions of Brazil.
Owing to reduced rate of vaccination the pandemic exhibited a negative impact on the global meningitis vaccines market.
Increasing incidences of meningitis is estimated to fuel growth of the global meningitis vaccines market over the forecast period. For instance, Netherlands-based academic publishing company, Elsevier Inc., published their data in April 2021, stating that in 2019 globally 2.5 million cases and 236,000 deaths were reported owing to meningitis.
Moreover, rising government initiatives in various countries and increasing regulatory authorities for battling the increasing incidences of meningitis is anticipated to augment growth of the global meningitis vaccines market over the forecast period. For instance, the World Health Organization along with its partners had launched Global Roadmap to Defeat Meningitis by 2030, a global strategy for combating meningitis in September 2021. This strategy aims to eliminate epidemics of bacterial meningitis, minimize the death rate by 70% and also halve the cases of meningitis by 2030.
Increasing product recalls and rising costs which are associated with meningitis vaccine is estimated to hamper growth of the global meningitis vaccines market. For instance, researchers from Johns Hopkins University, in 2018, calculated that it will not be cost-effective if all college students were vaccinated against meningitis B. Researchers also found that it will be beneficial, in case the vaccine for meningitis B costs less than US$ 65 for college students.
Ask For Discount Before Purchasing This Business Report : https://www.coherentmarketinsights.com/insight/request-discount/5042
- Pneumococcal Conjugate Vaccine
- Pneumococcal Polysaccharide Vaccine
- Meningococcal Vaccine
By Age Group:
By Distribution Channel:
- United Arab Emirates
- Saudi Arabia
- Cote d’Ivoire
- Rest of the World
Key players active in the global meningitis vaccines market are Eubiologics Co., Ltd., GlaxoSmithKline plc., CanSinoBIO, Sanofi S.A., Sinovac Biotech Co., Ltd., Merck & Co., Inc., Panacea Biotec Limited, Pfizer Inc., Espromed Bio, Novartis AG, LG Chem, Walvax Biotechnology Co., Limited., LG Chem, Incepta Pharmaceuticals Ltd., Bharat Biotech., Serum Institute of India Pvt. Limited., Chengdu Kanghua Biological Products, Vacsera, BIO MED and Zhi Fei Biological.
Direct Buy This Premium Research Report, Click Here @ https://www.coherentmarketinsights.com/insight/buy-now/5042
Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Meningitis Vaccines Market Size Analysis from 2022 to 2028
11.6 COVID-19 Outbreak: Meningitis Vaccines Industry Impact
Chapter 2 Global Meningitis Vaccines Competition by Types, Applications, and Top Regions and Countries
2.1 Global Meningitis Vaccines (Volume and Value) by Type
2.3 Global Meningitis Vaccines (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Meningitis Vaccines Sales, Consumption, Export, Import by Regions (2017-2022)
Chapter 5 North America Meningitis Vaccines Market Analysis
Chapter 6 East Asia Meningitis Vaccines Market Analysis
Chapter 7 Europe Meningitis Vaccines Market Analysis
Chapter 8 South Asia Meningitis Vaccines Market Analysis
Chapter 9 Southeast Asia Meningitis Vaccines Market Analysis
Chapter 10 Middle East Meningitis Vaccines Market Analysis
Chapter 11 Africa Meningitis Vaccines Market Analysis
Chapter 12 Oceania Meningitis Vaccines Market Analysis
Chapter 13 South America Meningitis Vaccines Market Analysis
Chapter 14 Company Profiles and Key Figures in Meningitis Vaccines Business
Chapter 15 Global Meningitis Vaccines Market Forecast (2022-2028)
Chapter 16 Conclusions
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027